Abstract

PurposeTumor delineation plays a critical role in radiotherapy for hepatocellular carcinoma (HCC) patients. The incorporation of MRI might improve the ability to correctly identify tumor boundaries and delineation consistency. In this study, we evaluated a novel Multisource Adaptive MRI Fusion (MAMF) method in HCC patients for tumor delineation.MethodsTen patients with HCC were included in this study retrospectively. Contrast-enhanced T1-weighted MRI at portal-venous phase (T1WPP), contrast-enhanced T1-weighted MRI at 19-min delayed phase (T1WDP), T2-weighted (T2W), and diffusion-weighted MRI (DWI) were acquired on a 3T MRI scanner and imported to in-house-developed MAMF software to generate synthetic MR fusion images. The original multi-contrast MR image sets were registered to planning CT by deformable image registration (DIR) using MIM. Four observers independently delineated gross tumor volumes (GTVs) on the planning CT, four original MR image sets, and the fused MRI for all patients. Tumor contrast-to-noise ratio (CNR) and Dice similarity coefficient (DSC) of the GTVs between each observer and a reference observer were measured on the six image sets. Inter-observer and inter-patient mean, SD, and coefficient of variation (CV) of the DSC were evaluated.ResultsFused MRI showed the highest tumor CNR compared to planning CT and original MR sets in the ten patients. The mean ± SD tumor CNR was 0.72 ± 0.73, 3.66 ± 2.96, 4.13 ± 3.98, 4.10 ± 3.17, 5.25 ± 2.44, and 9.82 ± 4.19 for CT, T1WPP, T2W, DWI, T1WDP, and fused MRI, respectively. Fused MRI has the minimum inter-observer and inter-patient variations as compared to original MR sets and planning CT sets. GTV delineation inter-observer mean DSC across the ten patients was 0.81 ± 0.09, 0.85 ± 0.08, 0.88 ± 0.04, 0.89 ± 0.08, 0.90 ± 0.04, and 0.95 ± 0.02 for planning CT, T1WPP, T2W, DWI, T1WDP, and fused MRI, respectively. The patient mean inter-observer CV of DSC was 3.3%, 3.2%, 1.7%, 2.6%, 1.5%, and 0.9% for planning CT, T1WPP, T2W, DWI, T1WDP, and fused MRI, respectively.ConclusionThe results demonstrated that the fused MRI generated using the MAMF method can enhance tumor CNR and improve inter-observer consistency of GTV delineation in HCC as compared to planning CT and four commonly used MR image sets (T1WPP, T1WDP, T2W, and DWI). The MAMF method holds great promise in MRI applications in HCC radiotherapy treatment planning.

Highlights

  • Hepatocellular carcinoma (HCC) is the most common primary liver cancer, which is among the most prominent causes of cancer-related deaths worldwide [1]

  • We have previously developed a Multisource Adaptive MRI Fusion (MAMF) method that is capable of producing a large number of fused MR images with multifaceted image contrasts for RT applications using a limited number of standard MR images as input [21]

  • The optimal image set with the highest tumor contrast-to-noise ratio (CNR) and a positive liver signal-to-noise ratio (SNR) in the database was selected for each patient automatically and exported in DICOM format for gross tumor volume (GTV) delineation

Read more

Summary

Methods

Ten patients with HCC were included in this study retrospectively. Contrastenhanced T1-weighted MRI at portal-venous phase (T1WPP), contrast-enhanced T1weighted MRI at 19-min delayed phase (T1WDP), T2-weighted (T2W), and diffusionweighted MRI (DWI) were acquired on a 3T MRI scanner and imported to in-housedeveloped MAMF software to generate synthetic MR fusion images. The original multicontrast MR image sets were registered to planning CT by deformable image registration (DIR) using MIM. Four observers independently delineated gross tumor volumes (GTVs) on the planning CT, four original MR image sets, and the fused MRI for all patients. Tumor contrast-to-noise ratio (CNR) and Dice similarity coefficient (DSC) of the GTVs between each observer and a reference observer were measured on the six image sets. Interobserver and inter-patient mean, SD, and coefficient of variation (CV) of the DSC were evaluated

Results
INTRODUCTION
Patient Data and Image Acquisition
Generation of Fused MRI Using Multisource Adaptive MRI Fusion
Gross Tumor Volume Delineation
Data Analysis
Patient Demographic Data
Tumor Contrast-to-Noise Ratio
DISCUSSION
CONCLUSION
ETHICS STATEMENT
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call